Study: Key mutations may worsen hearing loss from the chemotherapy drug cisplatin

The chemotherapy drug cisplatin can kill cancer, but it can also kill the sensory cells of the inner ear — causing permanent hearing loss. This hearing loss is likely to be more severe in individuals with Cockayne syndrome, according Read More »

July 9th, 2016|Announcements, Keck Net Intranet|

Health Sciences Campus getting major revamp

USC’s Health Sciences Campus — home of the university’s two hospitals and medical school, nearly 4,000 staff and faculty and 1,200 students — is undergoing a lot of change.

The 79-acre campus in Boyle Heights, about seven miles from the University Read More »

July 8th, 2016|Announcements, Keck Net Intranet|

Keck Medicine takes AIM at operational alignment

USC has been selected by the Association of Academic Health Centers International (AAHCI) to participate in the Aligned Institutional Mission (AIM) program.

The multi-year program is designed to better align clinical care, education, and research at academic health centers with guidance Read More »

July 8th, 2016|Announcements, Keck Net Intranet|

NIH awards USC and CHLA $36.6 million for clinical and translational science

A team of researchers led by Thomas Buchanan, MD, Michele Kipke, PhD, and Jonathan Samet, MD, of the Keck School of Medicine of USC have received a prestigious Clinical and Translational Science Award (CTSA) from the National Read More »

July 8th, 2016|Announcements, Keck Net Intranet|

USC Stem Cell researchers listen for clues about how the gene Atoh1 enables hearing

Non-mammals such as birds can recover from deafness as quickly as humans can recover from a cut or bruise. In contrast, when humans and other mammals sustain damage to the inner ear’s sensory cells, the resulting hearing loss is permanent.

In Read More »

July 1st, 2016|Announcements, Keck Net Intranet|